a public good project by the
Synthesis
Company
of California

© 2026

Antje Sucker | doi.page

0 works0 citations0 h-index

Antje Sucker

Essen University Hospital(DE)University of Duisburg-Essen(DE)

Publications by Year

Research Areas

Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Melanoma and MAPK Pathways, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management

Most-Cited Works

→ Genomic correlates of response to CTLA-4 blockade in metastatic melanoma(2015)2,936 cited
→ TERT Promoter Mutations in Familial and Sporadic Melanoma(2013)1,791 cited
→ Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,063 cited
→ The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma(2013)931 cited
→ Melanoma genome sequencing reveals frequent PREX2 mutations(2012)761 cited
→ Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature(2006)565 cited
→

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

(2016)

540 cited

→ Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG(2006)466 cited

→ RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors(2011)380 cited

→ Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab(2015)356 cited